Dr. Mark Bruce discusses the geographic disproportion of new COVID-19 cases, how the U.S. has most of the cases and he also talks about herd immunity. He is author of the book “Jackie, a Boy, and a Dog: A Warm Cold War Story”
INTERVIEWS
AAOS – AI in Orthopaedics
Dr. Joseph Schwab, Chief, Orthopaedic Spine Surgery, Massachusetts General Hospital, discusses his presentation from the American Academy of Orthopaedic Surgeons’ (AAOS) 2020 meeting titled “Artificial Intelligence in Orthopaedics: Machine Learning, Natural Language Processing, and Deep Learning”
PatchTelehealth – Physician Resources
Dr. Scott Patch of InterMed, P.A., Medical Group, in Maine discusses how his practice is using telehealth to manage patient care amid the COVID-19 pandemic with the ease of the eClinicalWorks® Healow platform.
A physician with Stage 4 Lung Cancer
Pediatrician Sanda Cohen talks about being diagnosed with Stage 4 Lung Cancer though she had never smoked. She also discusses how her treatment combination of chemotherapy and immunotherapy shrunk the main mass by nearly half in just 3 months.
Beyond Spring – Plinabulin
Rich Daly, Chief Operating Officer at Beyond Spring Inc., a biopharmaceutical company, discusses Plinabulin, the company’s lead asset currently in late-stage development for the treatment of non-small cell lung cancer and the prevention of neutropenia, a common and often severe side effect of chemotherapy that can cause patients to delay, downgrade, decrease or even discontinue their dose.
Phase 3b STARDUST study data on crohn’s disease
Dr. Jan Wehkamp, M.D. Vice President and Gastroenterology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC, talks about data from the Phase 3b, STARDUST study, showing that two doses of STELARA® (ustekinumab) induced clinical remission in two-thirds of patients with Crohn’s Disease (CD). STARDUST is the first study to compare a treat to target approach with standard of care in CD and using endoscopy to guide use of medication.
AAOS – differentiating lumbar spine from hip pathologies
Dr. Stuart Hershman, Orthopaedic Spine Surgeon at Massachusetts General Hospital, discusses his presentation from the American Academy of Orthopaedic Surgeons’ (AAOS) 2020 meeting titled “Is it the Back or Hip? Differentiating Lumbar Spine from Hip Pathologies: Key Points of Evaluation and Treatment”
Human milk oligosaccharides and Preemie Necrotizing Enterocolitis
Rachael Buck, Ph.D., Research Fellow at Abbott discusses necrotizing enterocolitis (NEC) in premature babies and the pre-clinical study from Johns Hopkins and Abbott, that was published in “Pediatric Research” that showed for the first time that certain human milk oligosaccharides (HMOs) can prevent the development of NEC.
Mental health during a pandemic
Dr. William Kassler, Deputy Health Officer, and Lead Population Health Officer, at IBM Watson Health, discusses his recently published perspective “Protecting Mental Health During a Pandemic”. He also authored another report for the IBM Institute for Business Value “ How Technology and Data Can Improve Access to Mental Health Resources”.
COVID-19 BiPAP device bridging option for ventilator shortage
Syneos Health Medical Director and critical care pulmonologist Dr. Keith Robinson discusses the Ventilator Initiative that is to raise awareness among healthcare providers of a bridging option, using intubated Bi-level Positive Airway Pressure (BiPAP) devices for appropriate COVID-19 patients. This is to address the predicted ventilator shortage. The open-access platform www.COVID-BiPAPinfo.com is now live and provides physicians with practical steps and training materials for use of BiPAP with intubated COVID-19 patients suffering respiratory failure.